Role of haemophilus influenzae lipooligosaccharide in the activation of innate and adaptive immunity by Choi, Joshua
Lakehead University
Knowledge Commons,http://knowledgecommons.lakeheadu.ca
Electronic Theses and Dissertations Electronic Theses and Dissertations from 2009
Role of haemophilus influenzae
lipooligosaccharide in the activation of
innate and adaptive immunity
Choi, Joshua
http://knowledgecommons.lakeheadu.ca/handle/2453/1633
Downloaded from Lakehead University, KnowledgeCommons
The Role of Haemophilus influenzae Lipooligosaccharide in the Activation of
Innate and Adaptive Immunity.
A Thesis Submitted to the Faculty of Graduate studies of Lakehead University
by JOSHUA CHOI 
In Partial Fulfilment of the Requirements for the Degree of 
MASTERS OF SCIENCE IN BIOLOGY
February 23, 2014
© Joshua Choi, 2014
ProQuest Number: 10611960
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is d e p e n d e n t  upon  th e  quality of th e  co p y  submitted.
In th e  unlikely e v e n t  th a t  th e  author did not send  a  c o m p le te  manuscript 
a n d  th e re  a re  missing p a g es ,  th e se  will b e  n o ted . Also, if material h a d  to  b e  rem oved ,
a n o te  will indicate  th e  deletion.
uest
ProQuest 10611960
Published by ProQuest LLC (2017). Copyright of th e  Dissertation is held by th e  Author.
All rights reserved.
This work is p ro te c ted  agains t unauthorized copying  under Title 17, United States C o d e
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
Acknowledgements
The last 18 months have been a time of discovery and knowledge. The experiences and 
relationships I’ve made will be ones that I will always cherish. The small type community of 
Lakehead provided a flourishing environment for me to grow as a researcher, both in the solitude 
of the lab and outside in the scientific community.
I would like to thank postdoctoral fellow Dr. Nix for his mentorship. His guidance has always 
provided me with a new perspective on whatever issues I was dealing with. I would also like to 
thank my committee members, Dr. Suntres and Dr. Schraft for their continued support and 
guidance during my Masters program.
I acknowledge the rest of the NOSM faculty and aspiring researchers; the mutual respect and 
kindness each member embodies has made working here a privilege.
Finally, I acknowledge and thank my supervisor, Dr. Marina Ulanova. Her work ethic and her 
knowledge in the field is a level all her students can look up to and strive to reach. I thank her for 
taking the chance on an inexperienced student with mediocre marks. She motivated me to push 
myself beyond my own expectations.
Abbreviations
APRIL A proliferation inducing ligand
APC Antigen presenting cells
ASC Apoptosis-associated speck-like protein containing a CARD
BAFF B cell activating factor
BAFFR B cell activating factor receptor
BCMA B cell maturation antigen
BSA Bovine serum albumin
COPD Chronic Obstructive Pulmonary Disease
FBS Fetal Bovine Serum





MALDI Matrix-assisted laser desorption/ionization
MHC Major histocompatibility complex
MyD88 Myeloid differentiation primary response gene 88
NAD Nicotine adenine dinucleotide
NF-kB Nuclear Factor Kappa B Transcription Factor
NLR NOD-like receptors
NOD nucleotide-binding oligomerization domain
NTHi Non-typeable Haemophilus influenzae
OM Otitis Media
PAFr Platlet activating factor receptor
PAMP Pattern association molecular patterns
PCho Phosphorylcholine
PRR Pattern recognition receptor
TACI Transmembrane activator and calcium modulator
THP-1 Human monocyte derived from acute monocytic leukemia cell line
TLR4 Toll-like receptor 4
TNF Tumor necrosis factor




List of Tables and Figures............................................................................................................... vii
Chapter I: The innate immune response against LOS of Haemophilus influenzae 
Abstract................................................................................................................................................ 1
1. Introduction..................................................................................................................................... 2
1.1 Innate Immune system ..................................................................................................................... 2
1.2 Biology of Haemophilus influenzae............................................................................................... 3
1.3 Lipooligosaccharide and its role in virulence...............................................................................5
1.3.1 LOS as a therapeutic target..................................................................................................... 8
1.4 Rationale............................................................................................................................................ 9
2. Study Objectives........................................................................................................................... 10
3. Materials and Methods.................................................................................................................11
2.1 Cell culture conditions................................................................................................................... 11
2.2 Purification of LOS compounds and analysis...........................................................................11
2.3 Cell stimulation and flow cytometry analysis...........................................................................11
2.4 Gene expression analysis...............................................................................................................12
2.5 Statistical analysis........................................................................................................................... 13
4. Results.............................................................................................................................................14
3.1 Characterization of lipid A of LOS isoforms by Matrix-Assisted Laser 
Desorption/Ionization analysis............................................................. *..............................................14
3.2 H. influenzae LOS exhibits decreased immunostimulatory abilities compared to E. coli 
LPS........................................................................................................................................................... 14
3.3 LOS significantly upregulates antigen presenting and co-stimulatory molecules................ 15
3.4 H. influenzae LOS has decreased capacity to activate pro-inflammatory response..............16
3.5 H. influenzae LOS induces upregulation of intracellular pattern recognition receptors 17
5. Discussion.......................................................................................................................................19
Chapter II- The adaptive immune response against LOS of Haemophilus influenzae 
Abstract..............................................................................................................................................40
1. Introduction................................................................................................................................... 41
1.1 The adaptive immune response.....................................................................................................41
1.2 The classical antibody production pathway................................................................................42
1.3 T-cell independent pathway of antibody production against L O S ......................................... 43
1.4 Rationale.......................................................................................................................................... 44
2. Study Objectives........................................................................................................................... 46
3. Materials and Methods.................................................................................................................47
2.1 Serum sam ples................................................................................................................................ 47
2.2 Antibody Analysis...........................................................................................................................47
2.3 Relative antibody unit calculation................................................................................................ 48
2.4 Statistical analysis...........................................................................................................................48
4. Results.............................................................................................................................................49
3.1 Eagan LOS induces natural immunity which may be age sensitive.......................................49
3.2 Rd LOS induces natural immunity which may not be age sensitive......................................49





List of Tables and Figures
Figure 1. A schematic diagram of the various molecules involved in antigen presentation 24
Figure 2. A schematic representation of LOS from H. influenzae strains Eagan, Rd, and Rd 
licllpsA  as determined by MALDI.........................................................................................................25
Figure 3. Flow cytometry analysis of ICAM-1 expression in response to LOS stimulation on 
THP-1 cells................................................................................................................................................ 26
Figure 4. Flow cytometry analysis of CD40 expression in response to LOS stimulation on THP-1 
cells..............................................................................................................................................................27
Figure 5. Flow cytometry analysis of CD58 expression in response to LOS stimulation on THP-1 
cells..............................................................................................................................................................28
Figure 6. Flow cytometry analysis of CD86 expression in response to LOS stimulation on THP-1 
cells..............................................................................................................................................................29
Figure 7. Flow cytometry analysis of HLA-ABC expression in response to LOS stimulation on 
THP-1 cells.................................................................................................................................................30
Figure 8. Flow cytometry analysis of HLA-DR expression in response to LOS stimulation on 
THP-1 cells.................................................................................................................................................31
Figure 9. Relative gene expression of TNF-a in response to LOS..stimulation.............................. 32
Figure 10. Relative gene expression of IL-lp in response to LOS stimulation..................... 33
Figure 11. Relative gene expression of IL-10 in response to LOS stimulation..................... 34
Figure 12. Relative gene expression of TLR4 in response to LOS stimulation.................... 35
Figure 13. Relative gene expression of NODI in response to LOS stimulation.................. 36
Figure 14. Relative gene expression of NOD2 in response to LOS stimulation.................. 37
Figure 15. The presence of naturally acquired IgG against Eagan LOS in healthy individuals.. .55
Figure 16. The presence of naturally acquired IgG against Rd LOS in healthy individuals.56
Figure 17. A comparative analysis of total IgG levels in sample population.................................. 57
Table 1. MALDI data of lipid A molecule from LOS compounds.................................................... 38
Table 2. Cell viability...............................................................................................................................39
Chapter I: The innate immune response against LOS of 
Haemophilus influenzae
Abstract
A Gram negative human bacterial pathogen Haemophilus influenzae expresses a truncated 
endotoxin known as lipooligosaccharide (LOS). Recent studies on H. influenzae LOS have 
highlighted its structural and compositional implications on bacterial virulence; however, the role 
of LOS in the activation of innate and adaptive immunity is poorly understood.
THP-1 monocytes were stimulated with either lipopolysaccharide (LPS) from E. coli or LOS 
compounds derived from Eagan, Rd, and Rd lie lips A H. influenzae strains. Cell surface 
expression of key antigen-presenting, co-stimulatory, and adhesion molecules, as well as gene 
expression of some cytokines and pattern recognition receptors were studied.
Eagan and Rd LOS had a lower capacity to induce the expression of the pro-inflammatory 
molecules, ICAM-1, CD40, CD58, TNF-a, and IL-lp compared to LPS. In contrast, antigen 
presenting (HLA-ABC, HLA-DR) and co-stimulatory (CD86) molecules, and the pattern 
recognition receptor, NOD2, were similarly upregulated in response to LOS and LPS. LOS from 
a mutant Rd strain (Rd licllpsA ) consistently induced higher expression of innate immune 
molecules than the wildtype LOS suggesting the importance of phosphorylcholine and/or 
oligosaccharide extension in cellular responses to LOS. An LOS compound with a strong ability 
to upregulate antigen-presenting and co-stimulatory molecules combined with a low pro- 




1.1 Innate Immune system
The innate immune system is often described as the first line of defence following microbial 
encounter by the host. Generally, the cells included in the innate immune repertoire are derived 
from myeloid progenitor stem cells in the bone marrow which then differentiate into various 
immune cells. These cells, among others, express a specific class of receptors known as pattern 
recognition receptors (PRR) which can recognize specific “non-self’ patterns motifs on 
microorganisms. The types of motifs that are recognized are largely conserved patterns and 
therefore not subject to antigenic variability. In this regard PRRs can effectively distinguish 
between microbial and human patterns and initiate an immune response to combat infection. The 
limitation is that the repertoire of conserved motifs, also known as pattern association molecular 
patterns (PAMP), recognized by PRRs is narrow and finite.
One of these PRRs is Toll-like receptor 4 (TLR4), which has a critical role in activating the 
inflammatory response. It is the only known Toll-like receptor in humans to activate two 
signalling cascades (Lee and Kim 2007). These two pathways, the myeloid differentiation 
primary response gene 88 (MyD88) and the TIR domain-containing adapter inducing IFN-P 
(TRIF) pathway, activate the downstream transcription factor nuclear factor kappa B (NF-kB) 
and interferon regulatory factor 3/7 (IRF3/7), respectively (Lee and Kim 2007). NF-kB 
activation results in the secretion of pro-inflammatory cytokines whereas IRF3/7 induces type I 
interferon; these combined signals result in the recruitment of leukocytes to the site of infection 
and also in the priming of naive T lymphocytes for the activation of the adaptive immune 
response.
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Apart from outer-membrane PRRs, there are also intracellular PRRs; some of these include 
nucleotide-binding oligomerization domain (NOD)-like receptors (NLR). Among the identified 
NLRs, a select few have been found to be able to form larger protein complexes known as 
inflammasomes. The role of inflammasome in microbial infection has yet to be fully elucidated, 
however it has been established that inflammasome is required for the full maturation of 
cytokines IL-1 p and IL-18 (Medzhitov 2007).
Antigen presentation is a key stage in activating T cells and requires the collaboration of several 
molecules (Fig. 1). HLA-ABC and HLA-DR are molecules directly involved in the presentation 
of peptide antigens to naive T cells. HLA-ABC and HLA-DR are both part of larger molecular 
complexes known as major histocompatibility 1 (MHC I) and MHC II, respectively. The CD 86 
molecule is also involved in antigen presentation and is recognized by its receptor on T cells, CD 
28. Furthermore, CD86 provides a necessary co-stimulatory signal to activate naive T cells. CD 
40 is also a co-stimulatory molecule which binds to its ligand known as CD40L, on T cells. This 
interaction provides further internal signals in resting T cells allowing for the priming of the 
adaptive response. Finally, CD54 (ICAM-1), and CD 58 both act as cellular adhesion molecules 
by binding to their receptors, Lymphocyte function-associated antigen 1 (LFA-1) and 
Lymphocyte function-associated antigen 2 (LFA-2), respectively. Both of these interactions play 
integral roles in strengthening the adhesion between a resting T cell and antigen presenting cells 
(APC).
1.2 Biology of Haemophilus influenzae
Haemophilus influenzae is a Gram-negative, pleomorphic coccobacillus found in the respiratory 
tract of humans; its mode of transmission is through inhalation via aerosol droplets (Turk 1984).
3
H. influenzae acquires hemin and nicotine adenine dinucleotide (NAD) from the host 
environment, both of which are struict requirements for growth (Fink and Gemelll 2006). H. 
influenzae was first isolated during the influenza pandemic in 1889 and was thought to be the 
causative agent for the flu disease caused by influenza virus (Fink and Gemelll 2006). H. 
influenzae has a relatively small genome compared to other Gram-negative bacteria allowing the 
Rd KW-20 strain to be the first free living organism with its genome completely sequenced 
(Fleischmann, Adams et al. 1995).
H. influenzae strains have been classified into two classes contingent on the expression of a
polysaccharide capsule. Strains expressing this capsule are known as encapsulated whereas
unencapsulated strains are denoted as non-typeable (NTHi). There are six antigenically distinct
polysaccharide capsules of the encapsulated serotypes designated as type a-f (Fink and Gemelll
2006). It has been well established that the type b encapsulated serotype (Hib), which contains a
repeating unit of ribosyl-ribitol-phosphate (PRP) as its polysaccharide capsule, is significantly
more virulent than the other serotypes (Moxon and Vaughn 1981, Turk 1984, Kimura and
Hansen 1986, Zamze and Moxon 1987), and was one of the leading causes of meningitis and
other invasive infections in young children (Turk 1984). Interestingly, more recent genomic
studies have indicated that the Hib isolates show distinct genetic variability when compared to
other capsule types (Power, Bentley et al. 2012). However, since the introduction of a PRP-
conjugate vaccine in the late 1980s, invasive diseases caused by Hib have been virtually
eliminated in developed countries (Kelly, Moxon et al. 2004). The dramatic decrease in the
incidence rates of Hib infections has raised concerns of emerging infectious diseases caused by
NTHi. Recent studies have documented increased rates of invasive NTHi disease in North
America and Europe, especially among the elderly and immunocompromised individuals
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(Dworkin, Park et al. 2007, Ladhani, Slack et al. 2010). Furthermore, there is a large body of 
work that corroborates the propensity of NTHi to cause disease (Swords, Buscher et al. 2000, 
Bouchet, Hood et al. 2003, Erwin and Smith 2007, Johnston, Zaleski et al. 2007, Schachern, 
Tsuprun et al. 2009, Hong, Peng et al. 2010).
The NTHi, as mentioned above, is the class of unencapsulated strains of H. influenzae. Although 
the polysaccharide capsule is a major virulence factor and seems to be a required component for 
invasive infections (Moxon and Vaughn 1981), NTHi has been implicated as the causative agent 
for respiratory tract infections. It is one of the leading causes of otitis media (OM) in children 
and exacerbations of chronic obstructive pulmonary disease (COPD) (Erwin and Smith 2007). 
Carriage rates of NTHi are up to 80% in human populations indicative of its commensal nature; 
however the specific mechanism behind the virulence factors that mediate the transition of NTHi 
from a commensal to pathogen is poorly understood. The exposed outer membrane of NTHi 
leaves the bacteria more susceptible to host clearance mechanisms; consequently, this causes a 
stronger selection for the expression of outer membrane moieties which are able to promote the 
bacteria’s resistance to the host’s defense pathways (Clark, Snow et al. 2012).
1.3 Lipooligosaccharide and its role in virulence
H. influenzae and a small subset of mucosal surface colonizing Gram-negative bacteria have 
been found to express lipooligosaccharide (LOS) rather than its more common counterpart 
lipopolysaccharide (LPS). LOS consists of a largely invariant tri-heptose oligosaccharide 
backbone covalently attached to a 3-deoxy-d-manno-oct-2-ulosonic acid moiety (KDO) 
otherwise known as the core region. Similar to LPS, the core region is covalently linked to the
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endotoxin lipid A. The H. influenzae lipid A region is embedded in the outer membrane of 
Gram-negative bacteria which consits of an acylated glucosamine disaccharide backbone. LOS is 
a cognate ligand for TLR4 and plays a key role in the activation of the inflammatory response 
(Lee and Kim 2007). The main phenotypical difference with LPS, is that LOS lacks the repeating 
sugar additions on the distal end of the molecule, known as the “O-antigen,” resulting in a rough, 
truncated phenotype. The truncated LOS of H. influenzae was first characterized by Flesher et al. 
(Flesher and Insel 1978); since then, the term lipooligosaccharide has been widely accepted in 
literature. However, despite the condensed structure, there is extensive inter- and intra-strain 
heterogeneity in the LOS glycoform populations. This heterogeneity is due to the variability of 
the oligosaccharide extensions that emanate from the tri-heptose core region which can be 
attributed to the molecular phenomenon known as phase variation (Swords, Jones et al. 2003, 
Schweda, Richards et al. 2007).
H. influenzae has several phase variable loci in its genome specific for LOS biosynthesis which 
results in a varying degree of expression from generation to generation. The common 
denominator sequence element among these loci is the presence of a tetranucleotide tandem 
repeat within the 5’ end predisposing the open reading frames to slipped-strand mispairing 
during DNA replication (Masked, Szabo et al. 1991, Swords, Jones et al. 2003). This simple 
mechanism removes the need for several regulatory factors that are normally expressed in larger 
genome bacteria whilst allowing for a varying expression of antigenic structures on the outer 
membrane (Swords, Jones et al. 2003).
The LOS of H. influenzae and its role in virulence has been of particular interest, especially for 
the NTHi strains, where the effect of LOS may be more prevalent than in the encapsulated
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strains. Interestingly, an earlier study had shown LOS composition contributed to the 
pathogenicity of invasive infections caused by encapsulated H. influenzae (Zwahlen, Rubin et al. 
1986), suggesting the virulence of LOS may not be limited to NTHi. Several studies have 
highlighted the role of LOS in bacterial virulence, i.e. in complement resistance (Griffin, Cox et 
al. 2005, Schweda, Richards et al. 2007, Langereis, Stol et al. 2012), adherence (Swords, 
Buscher et al. 2000), and host mimicry mechanisms (Bouchet, Hood et al. 2003, Johnston, 
Zaleski et al. 2007).
Adherence to the epithelial cells of the nasopharynx by H. influenzae is considered to be the 
initial interaction with the host to mediate colonization. Phosphorylcholine (PCho) expression on 
LOS has been implicated to mediate adherence and invasion by binding to the platelet activating 
factor receptor (PAFr) expressed on the epithelium (Swords, Buscher et al. 2000). Encapsulated 
strains seem to be far less efficient in their adherence which could be explained by their 
polysaccharide capsule essentially impeding the interactions between the bacteria and the host 
(Tomislav and Lena 2012). However NTHi strains, although much more susceptible to clearance 
by innate immune mechanisms, through various outer membrane structures, have evolved the 
ability to asymptomatically persist in the host without the protective coating of the 
polysaccharide which can be observed in the high carriage rates within the adult population. In 
addition to adherence, recent studies have looked into the role of PCho as a deterrent to 
bactericidal antibody activity (Clark, Snow et al. 2012). Although further investigation is 
warranted to assess the physiological implications in an in vivo environment, it is evident that 
PCho expression on LOS may be a multi-faceted component to virulence than initial thought.
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It has been well established that sialic acid addition to bacterial outer membranes mediates host 
mimicry mechanisms. As H. influenzae cannot synthesize sialic acid, sialyation is contingent on 
the bacteria’s capacity to scavenge N-acetyl-neuraminic acid (Neu5Ac) from the host. Similar to 
PCho addition, sialyation is a phase-variable occurrence encoded by licl and lic3 loci 
respectively (Weiser, Masked et al. 1990, Weiser, Schchepetov et al. 1997). Sialyation has been 
found to confer serum resistance specifically with regards to the alternative complement pathway. 
Sialic acid binds to factor H (FH) which selectively inhibits C3b deposition (Hallstrom and 
Riesbeck 2010). Although this mechanism has not been completely elucidated, sialyation of LOS 
in H. influenzae has been found to act as a major virulence factor in experimental otitis media in 
chinchilla models (Bouchet, Hood et al. 2003).
1.3.1 LOS as a therapeutic target
As LOS is invariably present in all H. influenzae strains irrespective of their serotype, it can be 
considered as a potential vaccine candidate to prevent infections caused by various strains, 
including NTHi. It is noteworthy that there have been earlier studies that investigated the 
potential use of LOS based vaccines; however to our knowledge, clinical trials did not go past 
phase I (Gu, Rudy et al. 2003). Additionally, it is unknown whether LOS derived from different 
strains of H. influenzae have different immunostimulatory activity. The composition of LOS may 
have significant implications on its immunostimulatory capacity and therefore on the overall 
efficacy of a vaccine. The role of LOS as a potential vaccine adjuvant should also be addressed. 
The conserved region of lipid A is a TLR4 ligand and is responsible for the intensity of the 
inflammatory response. There have been several studies which have focused on utilizing the 
stimulatory properties of lipid A while minimizing the potential toxic side effects (Lewicky,
Ulanova et al. 2011). Although lipid A of LPS is a potent immunostimulator, it is extremely 
toxic and has been found to induce septic shock when injected systemically (Opal, Scannon et al. 
1999), however this may not be the case for lipid A of LOS and is currently under investigation. 
In either case, there is a need for effective vaccine adjuvants that can boost the immune response 
to a specific antigen while minimizing potential exacerbations of systemic inflammation.
1.4 Rationale
The LOS of H. influenzae has been an area of significant research; however the fundamental 
question regarding the role of H. influenzae LOS as an immunostimulatory molecule has not 
been addressed and is poorly understood. An earlier study by Khair et al. looked at the 
expression of ICAM-1 and cytokines TNFa, IL-6, and IL-8 in human bronchial epithelial cells 
and found a significant increase in response to LOS stimulation (Khair, Devalia et al. 1994). 
Although this suggests that LOS has a role in the induction of the inflammatory response, it does 
not address the issue of whether LOS can act as an activator of the innate immune response and 
subsequent adaptive response. Another study found LOS of Histophilus somni to engage the NF- 
kB transcription factor, a potent activator of the innate immune response (Howard, Willis et al. 
2011); however the capacity of LOS to induce key co-stimulatory molecules indicative of the 
innate response and essential for modulating the bridge to adaptive immunity is unknown.
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2. Study Objectives
In this study we assessed the immunostimulatory capacities of three LOS compounds derived 
from 2 different strains of H. influenzae (Fig. 2) by measuring the expression of key co­
stimulatory and antigen-presenting molecules in human monocytic cells. Furthermore, the effect 
of LOS on pro-inflammatory and anti-inflammatory cytokine responses was measured. The 
results were compared to the effects of E. coli LPS, which has been previously studied and 
served as a reference for data interpretation (Lewicky, Ulanova et al. 2011). A LOS compound 
with a strong ability to stimulate the expression of co-stimulatory and antigen-presenting 
molecules combined with a low potential to stimulate pro-inflammatory responses may be 
considered as a potential vaccine candidate.
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3. Materials and Methods
2.1 Cell culture conditions
Human THP-1 monocytic leukemia cell line was obtained from ATCC (TIB-202) and stored in 
liquid nitrogen until thawed for culturing. Cells were maintained at 37°C, 5% CCb in RPMI- 
1640 media (Sigma-Aldrich, Oakville, ON, CAN) supplemented with 10% heat-inactivated fetal 
bovine serum (SAFC Biosciences, Lenexa, KS, USA) and 200 pi antibiotic-antimycotic (Life 
Technologies Inc. Burlington, ON, CAN). Cells were passaged when the culture density reached
1.0 xlO6 cells/ml; viability was determined by the trypan blue exclusion method using a ViCell 
XR Cell Viability Analyzer (Beckman Coulter, Brea, CA, USA).
2.2 Purification of LOS compounds and analysis
The LOS compounds were donated by Dr. A. Cox of the National research Council (Ottawa,
ON). The compounds were purified from H. influenzae strains Eagan (Hib), Rd (unencapsulated 
type d), and Rd licllpsA  (mutant) (Fig. 1) as previously described (Zhou, Altman et al. 2010). 
Profiling of fatty acid additions to lipid A was done via Matrix-assisted laser 
desorption/ionization (MALDI) analysis in Dr. Cox’s laboratory (Zhou, Altman et al. 2010). 
E.coli LPS 0111:B4 was obtained from Sigma-Aldrich (St. Louis, MO, USA). All compounds 
were solubilized in sterile distilled H2 O at a concentration of 1 mg/ml, aliquoted and stored at - 
20°C until use.
2.3 Cell stimulation and flow cytometry analysis
THP-1 cells were plated at 0.5 x 106 cells/2 ml/well in 12-well plates (Fisher Scientific, Fairlawn,
NJ, USA), incubated in 37°C, 5% C02for 24 hours and stimulated with LOS compounds at
concentrations of 1, 5, 10, and 15 pg/ml for an additional 24 hours at 37°C, 5% CO2 . Following
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stimulation, the cells were washed once with sterile PBS, centrifuged at 400 x g for 10 minutes 
and resuspended in PBS supplemented with 1% bovine serum albumin (Sigma-Aldrich). Cells 
were immunostained with fluorochrome-conjugated antibodies against ICAM-1, CD40, CD86 
(B7-2) (BD Biosciences, Mississauga, ON, CAN), CD58 (LFA-3) (Cedarlane, Burlington, ON, 
CAN), HLA-DR (MHC class II) (Biolegend, San Diego, CA, USA), or mouse IgGl isotype 
control at a concentration of 2.5 pg/ml. Primary unconjugated HLA-ABC (MHC class I) 
antibody (BD Biosciences) was added to cell suspension at a concentration of 5 pg/ml. All 
samples were incubated in the dark for 1 hour at 4°C. Samples with directly conjugated primary 
antibodies were washed once with PBS, centrifuged at 1000 x g for 5 min and resuspended in 
500 pi PBS for flow cytometry analysis. Samples with unconjugated primary antibodies were 
washed as above, resuspended in 1% BSA and incubated with secondary FITC-labelled rat anti­
mouse IgGl antibody (BD Biosciences) at a concentration of 2.5 pg/ml for 1 hour at 4°C. 
Following incubation with the secondary antibody, samples were washed with PBS and 
resuspended in 500 pi PBS for flow cytometry analysis. All samples were analyzed using a 
FACSCalibur flow cytometer with CELLQUEST PRO software (BD Biosciences), acquiring 
15,000 total events. The results were expressed as the mean fluorescence intensity (MFI) on FL- 
1 and FL-2 channels for FITC and PE conjugated antibodies, respectively.
2.4 Gene expression analysis
RNA was isolated from THP-1 cells using the Aurum Total RNA Mini Kit (Bio-Rad, Hercules, 
CA, USA) following stimulation with LPS or LOS compounds for 4 hours. RNA integrity was 
determined using the Experion system (Bio-Rad); product with “RNA Quality Indicator” values 
greater than 9 were used for downstream applications. 500 ng of total RNA was reverse
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transcribed using the First Strand cDNA Synthesis kit (Fisher Scientific) as per the 
manufacturer’s instructions. 25 ng of the synthesized cDNA was used for each reaction well 
including 10 jul of RT2 SYBR® Green Fluor qPCR Mastermix (Qiagen, Toronto, ON, CAN), and 
1 pi of primer sets TNFa, IL-lp, IL-10, TLR4, NODI, NOD2 (SA Biosciences, Mississauga,
ON, CAN) for a total reaction volume of 20 pi. PCR was performed using the iQ5 real-time PCR 
detection systems (Bio-Rad); samples were pre-heated at 95°C for 10 min followed by 40 cycles 
of the two-step cycling program. The denaturing temperature was set for 15s at 95°C followed by 
1 min at 60°C where annealing, fluorescence detection, and elongation occurred. The melt curve 
program immediately followed from 55°C to 95°C with plate reads every 0.5°C. The cycle 
threshold (Ct) values were used to compare relative amounts of measured transcripts, calculated 
as ACt= 2A-(Ct target gene -  Ct housekeeping gene)- To account for variability in the starting template 
amount this expression was normalized to housekeeping gene Peptidylprolyl isomerase B (PPIB) 
and the relative gene expression was calculated as AACt= 2A-(ACt experim ental -  ACt co n tro l)-
2.5 Statistical analysis
Data were expressed as mean of 3 independent experiments. Statistical significance was 
determined (GraphPad Prism 5.0, La Jolla, CA, USA) using one way ANOVA with Newman- 
Keuls Multiple Comparison post-hoc test. *P<0.05, **P<0.01, ***P<0.001 indicate significant 
difference compared to unstimulated control. +P<0.05, ++P<0.01, +++P<0.001 indicate 
significant difference between Rd licllpsA  and Rd wild type compounds. *P<0.05, ••P<0.01, 
•••PcO.001 indicate significant difference between LPS and LOS compounds.
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4. Results
3.1 Characterization of lipid A of LOS isoforms by Matrix-Assisted Laser 
Desorption/Ionization analysis.
The Lipid A structure consists of an invariant di-phosphorylated glucosamine disaccharide with a 
varying number of acyl chains. The MALDI analysis was performed on the lipid A of each LOS 
compound and the relative intensity of acylation was determined (Table 1). The major ion with 
the highest intensity for each compound was given an arbitrary unit of 1.0; all other ions were 
expressed relative to that. For each compound lipid A structures acylated with 4 fatty acid 
chains exhibited the highest intensity. LOS from Eagan and Rd had comparable ion intensities 
for all fatty acid additions; however, Rd licllpsA  LOS exhibited different intensities at both 3 
and 6 fatty acid additions at 0.25 and 0.7, respectively. This suggests that there is a higher 
population of 6-acylated lipid A structures in LOS Rd licllpsA  and a smaller population of 3- 
acylated lipid A compared to both Eagan and Rd LOS compounds.
3.2 H. influenzae LOS exhibits decreased immunostimulatory abilities compared to E. coli 
LPS
The capacity of LOS from H. influenzae to activate the innate immune response or induce co­
stimulatory signals for adaptive immunity has not been studied. To elucidate this question, cell 
surface expression of ICAM-1, CD40 and CD58 (LFA-3) was measured on THP-1 monocytic 
cells in response to LOS stimulation using flow cytometry analysis. LPS from E. coli strain 
0111 :B4, a potent innate immune activator served as a positive control (Lewicky, Ulanova et al. 
2011). Cell viability was not significantly affected by either LOS or LPS compounds (Table 2). 
Unstimulated THP-1 cells were used as a negative control.
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The adhesion molecule ICAM-1 was found to be constitutively expressed on unstimulated 
control (MFI ~ 10). ICAM-1 was significantly upregulated in response to stimulation with both 
Eagan and Rd licllpsA  LOS compounds at 1 pg/ml (Fig. 3) (P<0.01 and PcO.OOl respectively). 
LOS of the wild type Rd strain did not induce a significant increase over negative control at 1 
pg/ml; however, a significant dose response was observed at higher concentrations (5-15 pg/ml) 
(P<0.001). Both the Rd and Eagan LOS compounds induced lower expression of ICAM-1 
compared to E. coli LPS at 1 pg/ml (P<0.001); LOS of the Rd licllpsA  induced ICAM-1 
expression comparable with the effect of LPS. The effect of the Rd licllpsA  LOS was 
consistently higher compared to the wildtype, Rd LOS (up to 10 pg/ml). Similar results were 
observed with regards to the expression of CD40 and CD58 (Fig. 4, 5), where LOS compounds 
from both Eagan and Rd strains induced significantly less expression compared to LPS whereas 
Rd licllpsA  LOS induced comparable expression.
In summary, LOS from various strains of H. influenzae induced significant upregulation of all 
studied cell surface molecules on human monocytic cell line compared to unstimulated cells. Rd 
and Eagan LOS compounds induced significantly less expression of ICAM-1, CD40 and CD58 
compared to LPS whereas Rd licllpsA  induced expression comparable to the effect of LPS. The 
data suggest that LOS of H. influenzae exhibits a lower immunostimulatory potential that may be 
dependent on the LOS structure.
3.3 LOS significantly upregulates antigen presenting and co-stimulatory molecules
To address whether LOS would activate the adaptive immune response, the expression of antigen 
presenting molecules, HLA-ABC (MHC class I) and HLA-DR (MHC class II), as well as major
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co-stimulatory molecule in the T-cell antigen presenting cells axis, CD86 (B7-2), were measured 
in THP-1 cells stimulated with either H. influenzae LOS or E.coli LPS.
The CD86 expression was significantly upregulated in response to Eagan and Rd licllpsA  LOS 
compounds at a concentration of 1 pg/ml (PcO.Ol and PcO.OOl, respectively). For all 
compounds, a significant positive dose response was observed (Fig. 6) (PcO.OOl). With 
exception to Rd LOS, there was no observed difference in expression between LPS and LOS 
compounds at 1 pg/ml; furthermore, LOS from Rd licllpsA  did not confer an increased 
expression of CD86 compared to then wildtype, even at higher concentrations.
LOS compounds from Eagan, Rd and Rd licllpsA  induced significant expression of HLA-ABC 
and HLA-DR that was comparable to the positive control, LPS at 1 pg/ml (Fig. 7, 8) (PcO.OOl). 
At higher concentrations of all the compounds (5-15 pg/ml), a plateau effect was observed.
Our findings show that LOS of H. influenzae is able to significantly increase expression of both 
the antigen presenting molecules and the co-stimulatory molecule, B7-2, that is similar to the 
effect of LPS suggesting that LOS can act as a potent activator of the adaptive immune response.
3.4 H. influenzae LOS has decreased capacity to activate pro-inflammatory response
To further address the immunostimulatory capacity of LOS, gene expression of pro- 
inflammatory cytokines TNF-a and IL-1(3 were measured following 4 hours stimulation at 0.1 
and 1 pg/ml. LPS from E.coli was used as a positive control. Gene expression of anti­
inflammatory cytokine IL-10 was also measured via real-time PCR. Gene expression was 
normalized to housekeeping gene PPIB, and presented in fold change relative to unstimulated 
control.
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All LOS compounds induced significant upregulation of pro-inflammatory cytokines TNF-a and 
IL-lp (Fig. 9, 10) (PcO.OOl). However, similar to the effect on ICAM-1, CD40 and CD58, LOS 
of Eagan and Rd strains induced significantly less expression of both TNF-a and IL-ip when 
compared to LPS. In contrast, Rd licllpsA  LOS stimulation resulted in a 5-fold increase in IL-1 (3 
expression compared to LPS at a concentration of 1 pg/ml. Furthermore, Rd licllpsA  LOS 
stimulation at the concentrations of 0.1 and 1 pg/ml resulted in consistently higher gene 
expression of both pro-inflammatory cytokines compared to the wildtype.
Out of all of the LOS compounds, only Rd licllpsA  LOS was able to induce a significant 
upregulation of the anti-inflammatory cytokine IL-10 gene expression (P<0.05) (Fig 11). Both 
Eagan and Rd LOS induced less expression of IL-10 compared to LPS, however only the effect 
of Eagan LOS was statistically significant (P<0.05).
Our findings show Eagan and Rd LOS compounds were able to elicit transcriptional 
upregulation of key pro-inflammatory cytokines TNF-a and IL-1 p, however the response was 
significantly attenuated when compared to LPS of E.coli. Rd licllpsALOS was shown to 
consistently induce higher cytokine gene expression when compared to the wildtype or LPS at 1 
pg/ml.
3.5 H. influenzae LOS induces upregulation of intracellular pattern recognition receptors
In addition to inflammatory markers, we wanted to address whether LOS of H. influenzae would 
affect the genetic regulation of pattern recognition receptors (PRRs) such as TLR4, the cognate 
LOS receptor and intracellular PRRs such as NODI and NOD2. Gene expression was 
determined as described above.
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TLR4 gene expression in THP-1 cells did not significantly change upon stimulation with any 
compound except for Rd licllpsA  at the concentrations of 0.1 and 1 pg/ml (P<0.05) (Fig 12). The 
gene expression of NODI was not affected by any of the compounds (Fig. 13), whereas NOD2 
expression was significantly upregulated in response to all compounds at both concentrations 
(P<0.001) (Fig. 14).
Our findings show that NOD2 expression was increased by 4- to 6-fold with no observed 
differences between LPS or LOS stimulation. This suggests a possible relationship between the 
recognition of LOS and further downstream activation of the inflammasome complex.
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5. Discussion
Although invasive disease caused by H. influenzae has decreased considerably since the 
introduction of Hib conjugate vaccines, there is a concern for emerging infections caused by 
non-type b serotypes. This can partly be explained by the serotype replacement phenomenon 
where there is less competition for non-type b strains to colonize the ecological niche once 
occupied by Hib (Bemdsen, Erlendsdottir et al. 2012). Interestingly during the last decade, there 
has been an increase in reported invasive disease caused by NTHi, which was traditionally 
considered as a mucosal pathogen (Bamberger, Ben-Shimol et al. 2014). Whatever the cause 
behind the emergence of invasive non-type b serotypes, there is a pressing need for novel 
therapeutic treatments that would target all strains of H. influenzae regardless of serotype.
The H. influenzae LOS has several roles in bacterial virulence and has been the subject of
significant research in the past decade; however its potential role in vaccine development has
been of less interest. Although LOS is invariably present in all strains of H. influenzae, it shows
extensive inter and intra-strain heterogeneity (Swords, Jones et al. 2003). Consequently, the
implementation of LOS as a vaccine target has been difficult. Nonetheless, some recent findings
have been promising, for instance, protection against otitis media, caused by NTHi, was
observed in chinchillas that were immunized with LOS conjugate vaccines (Hong, Peng et al.
2010). Moreover, lipid A of LOS had been shown to be able to activate the TLR4 signalling
cascade, namely the MyD88 pathway (Khair, Devalia et al. 1994). Therefore, LOS can
potentially act as its own vaccine adjuvant as well as a general adjuvant which may be a more
suitable candidate as an adjuvant than current monophosphoryl lipid A (MPL) adjuvant. Studies
have shown the monophosphorylated nature of the MPL compound selectively activates the
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TRIF pathway of the TLR4 signalling cascade (Mata-Haro, Cekic et al. 2007, Bowen, Minns et 
al. 2012). However, it may be more beneficial for a lipid A compound to activate both TRIF and 
MyD88 pathways without the toxic pro-inflammatory side effects.
It is important to note that LPS was not tested at concentrations greater than 1 pg/ml and that all 
statistical comparisons between LOS and LPS were performed at this concentration. To address 
whether the observed effect of LOS stimulation was indeed dose dependent, higher 
concentrations from 5-15 pg/ml were tested for only LOS compounds. A dose response was not 
tested for LPS because higher doses have been previously implicated in septic shock models and 
would have been clinically irrelevant for our purposes (Priest, Schlievert et al. 1989). Thus a 
concentration of 1 pg/ml LPS was used as a reference which had been optimized in several 
studies (Maaetoft-Udsen, Vynne et al. 2013, Nebel, Arvidsson et al. 2013).
Our findings show that LOS derived from Eagan and Rd strains of H. influenzae were able to 
elicit an in vitro innate immune response resulting in the upregulation of co-stimulatory and 
antigen presenting molecules, HLA-ABC, HLA-DR and CD86, comparable to that of LPS.
These surface molecules play critical roles in the priming of naive T cells essential for the 
activation of the adaptive immune response.
We also found that Eagan and Rd LOS had a decreased capacity to stimulate the surface
expression of CD40, CD58 and ICAM-1, as well as gene expression of TNF-a and IL-lp,
compared to LPS. ICAM-1, TNF-a, and IL-ip are critical mediators of inflammation where high
expression has been correlated with potent pro-inflammatory responses via the recruitment of
immune cells and the propagation of inflammatory cytokines (Lisby, Ralfkiaer et al. 1989,
Cromwell, Hamid et al. 1992). This suggests that Eagan and Rd LOS elicits a decreased pro-
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inflammatory effect compared to LPS making them attractive candidates for vaccine 
development.
All compounds were found to significantly upregulate NOD2 which has been found to directly 
interact with NLRP1, NLRP3 and NLRP12 inflammasomes (Moreira and Zamboni 2012). In 
contrast, NODI was unaffected by either LOS or LPS; indeed, no relationship between the 
inflammasome complexes and NODI have been previously identified (Moreira and Zamboni
2012). The addition of NOD2 activation widens the scope of our model, aside from 
inflammasome activation, NOD2 has been shown to interact with several different signalling 
pathways (Moreira and Zamboni 2012). Although the exact role of NOD2 in bacterial infection 
has yet to be fully elucidated, the activation of NOD2 has been implicated in T cell 
differentiation and host response to pulmonary pathogens such as Chlamydophila pneumonia 
(Shimada, Chen et al. 2009). This suggests that the role of LOS during infection may not be 
limited to just the inflammatory response.
To address whether LOS stimulation had a toxic effect on the cells at various concentrations, cell 
viability was measured. It was found that LOS had no effect on viability with exception of the 
highest concentration, i.e. 15 pg/ml (Table 2). However, in our experiments, this concentration 
did not have any significant biological impact; a plateau effect was observed for the majority of 
surface molecules at 10 pg/ml.
Rd liclIpsALOS was found to consistently induce a stronger effect than the wildtype on the
expression of surface molecules ICAM-1, CD40, CD58 and pro-inflammatory cytokines TNF-a
and IL-lp. The main compositional differences between Rd UcllpsA and Rd are the deletions of
phosphorycholine (PCho) at Heptose I and oligosaccharide extension at Heptose III (Fig. 1).
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Previous work has shown that the loss of this oligosaccharide extension in this strain resulted in a 
decrease in complement resistance (Griffin, Cox et al. 2005). Our findings add to this by 
suggesting that the oligosaccharide extension may also have a role in attenuating the expression 
of aforementioned inflammatory markers as can be observed by the wildtype, Rd LOS. 
Moreover, PCho has been implicated in numerous studies as a virulence factor and adhesion 
molecule that enhances immune evasion by H. influenzae (Swords, Buscher et al. 2000, Clark, 
Snow et al. 2012). Whether PCho also has a role in reducing the inflammatory response in vivo 
has yet to be elucidated.
The number of acyl chains on the lipid A of each compound is of interest and should be 
addressed. Rd licllpsA  LOS was found to have relatively less tri-acylated lipid A isoforms and 
considerably higher amounts of hexa-acylated lipid A compared to both Eagan and Rd lipid A 
(Table 1). Previous studies have shown that the immunostimulatory properties of LPS molecules 
are determined by the structure of lipid A (Schromm, Brandenburg et al. 2000). Furthermore, a 
correlation can be found with acylation of lipid A and an inflammatory response, where 
increased acylation is generally associated with more potent inflammatory responses and low 
acylation is associated with a weaker response (Maaetoft-Udsen, Vynne et al. 2013). This 
suggests that the pro-inflammatory capacity of Rd licllpsA  LOS observed in our experiments 
may also be due to the acylation state of its lipid A. A recent study shows another Gram-negative 
pathogen, Shigella flexneri is able to modify the acylation state of its lipid A following invasion, 
thereby enhancing its immune evasion (Paciello, Silipo et al. 2013). This finding has not yet been 
observed in H. influenzae LOS and therefore further research is warranted to determine how 
much of the observed immunostimulatory effect is attributed to acylation and/or compositional 
motifs.
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The balance between inflammatory and anti-inflammatory cytokines has been well described. It 
has been found that a strong inflammatory response is correlated with a strong anti-inflammatory 
response in order to maintain equilibrium (Ostrowski, Rohde et al. 1999). Unlike other LOS 
compounds, Rd licllpsA  LOS alone was able to significantly increase IL-10 expression, which 
was expected since it also had the largest effect on the pro-inflammatory markers compared to 
other LOS compounds.
In summary, we have shown that LOS of H. influenzae strains, Eagan and Rd, are able to induce 
the upregulation of key co-stimulatory and antigen presenting molecules in human monocytic 
cells, as well as the production of inflammatory cytokines. Although these compounds were able 
to stimulate the expression of pro-inflammatory markers, their effect was markedly diminished 
in comparison to the toxic LPS compound of E. coli. Furthermore, all LOS compounds were 
found to upregulate NOD2 which has further downstream implications for the inflammasome 
complexes. Rd licllpsA  LOS was found to consistently induce a stronger response than the 
wildtype on surface molecules and cytokines indicative of inflammation. However this was not 
observed for antigen presenting and co-stimulatory molecule expression. Whether this effect is 
due to the PCho or oligosaccharide deletion on Rd licllpsA  LOS compound is yet to be 
determined. As LOS is invariably present in all H. influenzae strains it makes it an attractive 
candidate for vaccine development. Furthermore, the moderate immunostimulatory ability of 
LOS may be of consideration for potential adjuvant development and may offer a more robust 
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Fig 1. A schematic diagram of the various molecules involved in antigen presentation.
Molecules of interest include: ICAM-1, CD40, MHC I, MHC II, CD 58, CD86 and cytokines, 
TNF-a, IL-1 (3, IL-10. This figure was taken and modified from The Community College of 












For Rd: R l=PCho, R2=H & R3=GalNAc-(3-l-3-Gal-a-]-4-Gal-(3-l-4-Glc 
For Rd licllpsA : R1=H, R2=H & R3=H
For Eagan: R1=H, R2=G al-a-l-4-G al-P-l-4-G lc-P-l-4-G lc & R3=Gal
Figure 2. A schematic representation of LOS from H. influenzae strains Eagan, Rd, and Rd 
licllpsA  as determined by MALDI. Represented in the LOS structure: (Kdo) 2-keto-3- 
deoxyoctulosonic acid; (Hep) heptose; (Glc) glucose; (Gal) galactose; (GalNAc) N- 
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Figure 3. Flow cytometry analysis of ICAM-1 expression in response to LOS stimulation on 
THP-1 cells. Negative control was untreated, medium alone where LPS stimulation at 1 pg/ml 
was the positive control. THP-1 cells were stimulated with LOS compounds for 24 hours at 
concentrations 1,5, 10, and 15 pg/ml and cell expression was measured. Data represents the 

















Figure 4. Flow cytometry analysis of CD40 expression in response to LOS stimulation on 
THP-1 cells. Negative control was untreated, medium alone where LPS stimulation at 1 pg/ml 
was the positive control. THP-1 cells were stimulated with LOS compounds for 24 hours at 
concentrations 1, 5, 10, and 15 pg/ml and cell expression was measured. Data represents the 
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Figure 5. Flow cytometry analysis of CD58 expression in response to LOS stimulation on 
THP-1 cells. Negative control was untreated, medium alone where LPS stimulation at 1 pg/ml 
was the positive control. THP-1 cells were stimulated with LOS compounds for 24 hours at 
concentrations 1, 5, 10, and 15 pg/ml and cell expression was measured. Data represents the 
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Figure 6. Flow cytometry analysis of CD86 expression in response to LOS stimulation on 
THP-1 cells. Negative control was untreated, medium alone where LPS stimulation at 1 (Ltg/ml 
was the positive control. THP-1 cells were stimulated with LOS compounds for 24 hours at 
concentrations 1,5, 10, and 15 pg/ml and cell expression was measured. Data represents the 
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Figure 7. Flow cytometry analysis of HLA-ABC expression in response to LOS stimulation 
on THP-1 cells. Negative control was untreated, medium alone where LPS stimulation at 1 
pg/ml was the positive control. THP-1 cells were stimulated with LOS compounds for 24 hours 
at concentrations 1, 5, 10, and 15 pg/ml and cell expression was measured. Data represents the 
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Figure 8. Flow cytometry analysis of HLA-DR expression in response to LOS stimulation 
on THP-1 cells. Negative control was untreated, medium alone where LPS stimulation at 1 
pg/ml was the positive control. THP-1 cells were stimulated with LOS compounds for 24 hours 
at concentrations 1, 5, 10, and 15 pg/ml and cell expression was measured. Data represents the 
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Figure 9. Relative gene expression of TNF-a in response to LOS stimulation. THP-1 cells 
were stimulated with LOS compounds for 4 hours at concentrations 0.1 and 1 pg/ml. RNA was 
extracted and genetic expression was measured using real-time PCR and presented as fold 
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Figure 10. Relative gene expression of IL-ip in response to LOS stimulation. THP-1 cells 
were stimulated with LOS compounds for 4 hours at concentrations 0.1 and 1 pg/ml. RNA was 
extracted and genetic expression was measured using real-time PCR and presented as fold 
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Figure 11. Relative gene expression of IL-10 in response to LOS stimulation. THP-1 cells 
were stimulated with LOS compounds for 4 hours at concentrations 0.1 and 1 pg/ml. RNA was 
extracted and genetic expression was measured using real-time PCR and presented as fold 
























Figure 12. Relative gene expression of TLR4 in response to LOS stimulation. THP-1 cells 
were stimulated with LOS compounds for 4 hours at concentrations 0.1 and 1 pg/ml. RNA was 
extracted and genetic expression was measured using real-time PCR and presented as fold 


























Figure 13. Relative gene expression of NODI in response to LOS stimulation. THP-1 cells 
were stimulated with LOS compounds for 4 hours at concentrations 0.1 and 1 pg/ml. RNA was 
extracted and genetic expression was measured using real-time PCR and presented as fold 



























Figure 14. Relative gene expression of NOD2 in response to LOS stimulation. THP-1 cells 
were stimulated with LOS compounds for 4 hours at concentrations 0.1 and 1 pg/ml. RNA was 
extracted and genetic expression was measured using real-time PCR and presented as fold 
change relative to unstimulated control. Data represents mean ± SEM (n=3).
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Table 1. MALDI data expressed in relative intensity of lipid A molecule from LOS 







Proposed Composition Number of 
acylations
Eagan 1161.7 .9 2 GlcN, 2 P, 2 C-14:0-3-OH, 1 C-14:0 3
1387.9 1 2 GlcN, 2 P, 3 C-14:0-3-OH, 1 C-14:0 4
1598.1 .2 2 GlcN, 2 P, 3 C-14.0-3-OH, 2 C-14.0 5
1824.3 .3 2 GlcN, 2 P, 4 C-14:0-3-OH, 2 C-14:0 6
Rd 1161.7 0.7 2 GlcN, 2 P, 2 C-14:0-3-OH, 1 C-14:0 3
1387.9 1 2 GlcN, 2 P, 3 C-14:0-3-OH, 1 C-14:0 4
1598.1 0.1 2 GlcN, 2 P, 3 C-14:0-3-OH, 2 C-14:0 5
1824.3 .2 2 GlcN, 2 P, 4 C-14:0-3-OH, 2 C-14:0 6
Rd
licllpsA
1161.7 .25 2 GlcN, 2 P, 2 C-14:0-3-OH, 1 C-14:0 3
1387.9 1 2 GlcN, 2 P, 3 C-14:0-3-OH, 1 C-14:0 4
1598.1 .1 2 GlcN, 2 P, 3 C-14:0-3-OH, 2 C-14:0 5
1824.3 .7 2 GlcN, 2 P, 4 C-14:0-3-OH, 2 C-14:0 6
Represented in lipid A: (GlcN) Glucosamine; (P) Phosphate; (C-14:0-3-0H), (C-14:0) Fatty acid 
chains;
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Table 2. Cell viability (% viable cells). Trypan Blue exclusion test, mean of n=3 ± SD, 
following treatment with Eagan, Rd and Rd licllpsA LOS after 24 hours.
Concentration Control LPS Eagan Rd Rd licllpsA
0 pg/ml 97.2 ± 1.5 - - - -
1 pg/ml - 97.5 ± 1.4 97.2 ±0.6 97.9 ±0.5 97.6 ± 1.5
5 pg/ml - - 96.7 ± 1.6 97.3 ± 1.7 97.27 ± 1.6
10 pg/ml - - 94.6 ± 2.6 97.3 ±0 .6 93.3 ±0 .6
15 pg/ml - - 81.47 ±6.4 84.9 ±3.2 81.6 ±5 .4
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Chapter II- The adaptive immune response against LOS of 
Haemophilus influenzae
Abstract
The lipooligosaccharide (LOS) of Haemophilus influenzae is a truncated polysaccharide antigen 
expressed on the outer membrane. The structure and composition of LOS is highly 
heterogeneous among strains and it is unclear whether it can induce a natural antigen-specific 
antibody response. Serum was acquired from consenting healthy individuals and antibodies 
specific for Eagan and Rd LOS compounds of H. influenzae were measured using an indirect 
ELISA.
Out of 72 serum samples measured, 71 were positive for Eagan LOS specific IgG antibodies, 
however antibody titers were significantly different among age groups. All 72 samples were 
positive for Rd LOS specific IgG with no differences among age groups. Futhermore, Rd LOS 
was found to induce significantly higher IgG levels when compared to Eagan LOS.
These findings make a strong case for the natural antigenicity of H. influenzae LOS compounds 
which has further medical implications. If used as a potential vaccine candidate, LOS would act 
as an effective boost to an already existing natural immune response against this antigen.
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1. Introduction
1.1 The adaptive immune response
Adaptive immunity is considered to be a higher order of immune responses compared to innate 
immunity. As innate immune response can be found in all multi-cellular organisms, adaptive 
immunity can only be found in vertebrates (Medzhitov and Janeway 1997). Although innate and 
adaptive immune responses are usually identified as the two distinct arms of immunity, their 
roles are not independent, or mutually exclusive. In fact, innate immune activation is a necessary 
prerequisite for the development of an adaptive immune response. The innate immune system 
also has a critical role in making initial contact with microorganisms and functions to keep the 
bacterial population at bay. During pathogenic infection however, the innate immune response is 
overwhelmed and cannot contain the invasion. It is at this point where adaptive immunity plays 
an essential role in neutralizing the foreign microbial invasion.
The adaptive immune response can be described as a clonal expansion of a germline encoded 
antigen-specific directed response (Medzhitov and Janeway 1997). The process of hypermutation 
in lymphocytes that results in the recombination of genes allow for literally billions upon billions 
of different sequences that antibodies can recognize (Alt, Oltz et al. 1992). Adaptive immunity is 
largely mediated by B and T lymphocytes. Regulated by selection, only the lymphocytes with the 
highest affinity for the target antigen become activated effector cells (Berek and Ziegner 1993). 
Within the adaptive immunity paradigm, there are two types of responses which are defined as 
cell-mediated and humoral. Cell mediated adaptive responses are dependent on effector T 
lymphocytes, known as cytotoxic T cells which destroy pathogen infected cells upon binding. 
Cell-mediated immunity is the most significant in defence against intracellular pathogens. In the
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case of humoral immunity, both T and B lymphocytes are needed for the clonal expansion of 
effector cells to produce an excess of antigen specific antibodies which travel to the site of 
infection. The antibodies assist in pathogen opsonization, neutralization, and complement 
activation eventually leading to the elimination of the microorganism. The whole process is 
highly regulated to prevent the activation of lymphocytes that recognize “se lf’ antigens which 
can result in various auto-immune diseases. The recognition repertoire of antibodies is 
practically unlimited; however, its limitation lies in its initiation. The processes involved to 
mount an effective adaptive immune response are long and energy costly which can take up to as 
many as 7 days. Thus an integrated response of innate and adaptive immunity is necessary for 
successful host defence against microbial infections.
1.2 The classical antibody production pathway
The classical antibody production pathway is a series of biochemical events that have been 
extensively studied over the last 30 years. Simply put, the cumulative contributions of both 
innate and adaptive immunity are realized in the production of antigen specific antibodies. The 
major point of inference is that APCs, such as dendritic cells or macrophages of the innate 
immune cell repertoire, invoke the co-operation of the T lymphocytes (Jawa, Cousens et al.
2013). This occurs via the MHC molecules which physically present foreign peptide sequences 
to naive T cells, in the presence of additional co-stimulatory signals, resulting in the activation of 
the T cell. The activated T cell’s main effector function, with respect to antibody production, is 
providing the activating and co-stimulatory signals to resting B cells. Subsequently, activated B 
cells undergo morphological changes to become plasma cells which are responsible for the mass 
production of antigen-specific antibodies (Jawa, Cousens et al. 2013). This classical antigen
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presentation pathway has also been called the T-cell dependent pathway, due to the involvement 
of T cells and the necessary signals it provides for B cell activation. The drawback of this 
pathway lies within the antigen presentation. T cell receptors can only recognize MHC class 
molecules which are limited in their ability to present only peptide fragments. This means 
antigenic sugars, lipids, and nucleic acid motifs would not induce production of antibodies 
directed against them through the activation of T cells (Buus 1992). Thus, an alternative pathway 
is necessary for non-protein antigens.
1.3 T-cell independent pathway of antibody production against LOS
Non-protein antigens, as mentioned above, do not induce the classical pathway of antibody 
production; however, antibodies specific for non-protein antigens can still be found in the serum. 
This is due to the activation of the T-cell independent pathway. It was traditionally thought that 
the host immune system could produce antibodies against non-protein antigens such as the 
polysaccharide capsule of encapsulated bacteria, or glycolipids such as LOS, only by way of 
crosslinking of B ceil receptors (Schreiber 2012). Although T cell receptors are limited to 
recognizing peptide antigens, B cell receptors can recognize a range of different three 
dimensional antigenic motifs (Buus 1992). Thus when two or more B cells would bind to a non­
protein antigen, this would provide a sufficient internal signal to activate the B cell without any 
influence from T cells (Schreiber 2012). However this type of response was not comparable with 
a T-cell dependent pathway which produces a very robust, high affinity antibody response with a 
high degree of adaptability to possible antigen mutations. In contrast, crosslinking resulted in a
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response with low affinity, low somatic hypermuation, virtually no isotype switching and poor 
memory (Mond, Vos et al. 1995).
Recent studies have shown that there are other factors that affect the T-cell independent 
paradigm. A specialized group of tumour necrosis family (TNF) receptors are expressed on B 
cells known as the B cell activating factor receptor (BAFFR), the B cell maturation antigen 
(BCMA) and the transmembrane activator and calcium modulator (TACI) which recognize 
specialized cytokines secreted by innate immune cells such as monocytes and dendritic cells. B 
cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) are two such cytokines 
found to provide additional signals in activating the B cell, resulting in a stronger T-cell 
independent antibody response (Schreiber 2012). Interestingly, TACI KO mice were able to 
produce a normal antibody response against T-cell dependent antigens, however responses 
against a T-cell independent antigen were virtually abolished (von Bulow, van Deursen et al. 
2001). Moreover engagement of TLR4 receptors was found to increase BAFF and APRIL 
secretion, which is integral to the antibody response against non-protein antigens (Ng, Ng et al. 
2006). Whether LOS of H. influenzae has a role in inducing BAFF and APRIL mediated 
antibody secretion is not part of the scope of this study, however it remains a question that still 
needs to be investigated.
1.4 Rationale
In a post Hib vaccine era, invasive infections have been largely attributed to NTHi; there 
is a growing concern to address the increased incidence rates (Tanaka, Kurosaki et al. 2013, 
Bamberger, Ben-Shimol et al. 2014). There have been several studies which have measured the 
antibody response against whole cell NTHi; research indicates both healthy and
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immunocompromised subjects have detectable levels of anti-NTHi antibody, however 
immunocompromised subjects presented a significantly different Immunoglobulin G (IgG) 
subclass population, CD40L expression, and changes in the cytokine profile (King, Hutchinson 
et al. 2003, King, Ngui et al. 2008). The question of whether there are naturally acquired 
antibodies against LOS has not been fully elucidated. Recent work by Clark et al. found the 
presence of anti-LOS antibodies in a single normal human serum sample (Clark, Snow et al. 
2 0 1 2 ), however whether this finding applies to a larger sample population is unknown. 
Furthermore, whether these naturally acquired antibodies against LOS are functional with 
regards to bactericidal activity is also unknown and is currently being investigated.
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2. Study Objectives
In this study, we measured the presence of naturally acquired anti-LOS antibodies in 
serum samples from healthy individuals against LOS of Eagan and Rd strains of H. influenzae. 
The serum samples were divided into three age groups corresponding to age dependent changes 
in the adaptive immune system (Ligthart, Corberand et al. 1984). As LOS is present on all strains 
of H. influenzae, a comprehensive understanding of whether LOS can induce naturally acquired 
anti-LOS antibodies could provide novel insights in vaccine development against all serotypes of 
H. influenzae.
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3. Materials and Methods
2.1 Serum samples
Serum samples from adults without any significant medical conditions residing in Thunder Bay 
and surrounding areas were obtained with informed consent by a registered phlebotomist. A total 
of 72 serum samples were measured; the donor ranged from 18-80 years. Blood was drawn into 
serum separator tubes, which were centrifuged at 1500 x g for 10 min. Serum was decanted and 
aliquoted into sterile eppendorf tubes, followed by immediate storage at -80 °C. Age groups 
were determined according to the SENIEUR protocol criterion (Ligthart, Corberand et al. 1984) 
with modifications as described (Plackett, Boehmer et al. 2004). The study was approved by the 
Research Ethics Board of Lakehead University.
2.2 Antibody Analysis
Serum antibody concentrations were measured using an indirect ELISA where purified LOS
compounds derived from Eagan and Rd strains of H . influenzae were used for coating of
Polystyrene 96-well Immuno Plate (Cedarlane) at 2.5 gg/ml/50 pi in 0.05 M carbonate buffer
containing 0.02 M MgCL, pH 9.8 at 37°C for 3 hours followed by overnight incubation at 4°C.
The wells were blocked with 1% BSA-PBS for 1 hour at room temperature and washed with
PBS-0.05% Tween 20 (PBST). Sera was serially diluted and added to the wells for 1 hour at
room temperature followed by washing with PBST. Mouse anti-human IgG horseradish
peroxidase (HRP) conjugated antibody was added for an additional hour followed by washing
and incubation with the substrate 3 ,3 \5 ,5 ’-Tetramethylbenzidine (TMB) (Mandell Scientific,
Guelph, ON, CAN) for 30 minutes. Then, 1 N HC1 was added as a stop solution and absorbance
(A4 5 0  nm-6 3 0 nm) was determined with an automated microplate reader (Bio Tek Powerwave XS).
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2.3 Relative antibody unit calculation
Serum samples were run at dilutions of 1:400, 1:800, and 1:1600 in duplicates. Duplicates with 
coefficient of variation (CV) greater than 15% were excluded from calculations. The mean of 
each optical density (O.D.) at 1:800 and 1:1600 was back-calculated to 1:400 where outliers 
were excluded if the CV of the 3 values was greater than 15%. One serum sample was chosen 
arbitrarily to be the relative standard to compare all other samples. All samples were normalized 
to the standard and expressed in relative units.
2.4 Statistical analysis
Data were expressed as the geometric mean with 95% confidence intervals. Statistical 
significance was determined (GraphPad Prism) using the Kruskal-Wallis test with Dunns post- 
hoc test, unless otherwise specified. *P<0.05, **P<0.01 were considered significant.
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4. Results
3.1 Eagan LOS induces natural immunity which may be age sensitive
The question of whether LOS of H. influenzae can induce an antibody specific response has not 
been fully elucidated. Furthermore, there have been no studies, to our knowledge, that have 
addressed the antibody response against LOS in a human population. Thus, in order to detect 
specific antibodies against Eagan LOS an indirect ELISA was performed using serum samples 
collected from 72 healthy individuals that were divided into three age groups of 18-34, 35-59, 
and 60-80. The IgG isotype was measured which indicates a secondary response, i.e. the host had 
previously encountered LOS resulting in clonal expansion and isotype switching from IgM to 
IgG.
Data were expressed in relative units due to the non-existence of an LOS standard to derive 
absolute concentrations. Blank control wells were measured at less than 0.1 O.D. and were used 
as the negative control. With exception to one sample in the 18-34 age group, all samples were 
well above 0.1 O.D. indicating the presence of anti-Eagan LOS IgG antibodies (Fig. 15). 
Furthermore, the presence of Eagan LOS specific antibodies seemed to be age sensitive as well; 
the mid-age group (35-59) had significantly more LOS specific IgG antibodies than the younger 
age group (P<0.05). The older age group also had lower antibody levels than the mid age group 
however this difference was not significant.
3.2 Rd LOS induces natural immunity which may not be age sensitive
To address whether the observed presence of Eagan LOS specific antibodies in healthy 
individuals would be analogous for Rd LOS, ELISA plates were coated with Rd LOS overnight
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at the same concentration as Eagan LOS and specific IgG were measured in serum samples using 
the same methodology described for Eagan LOS.
All serum samples in all age groups exhibited presence of Rd LOS specific IgG antibody, 
however no statistical differences were observed between the age groups (Fig. 16). Whether this 
effect is attributed to the age-dependent changes in the B cell memory repertoire or the antigenic 
nature of the Rd LOS is unknown and is warranted further investigation.
3.3 Rd LOS induces higher IgG concentrations in the sample population
To assess if there were any differences in IgG levels between LOS compounds, the raw O.D. 
values were used for comparison. It is important to note that relative units were not used in this 
case as there was no mutual point of reference for both Eagan and Rd values. As each value was 
a paired observation, statistical significance was determined using a two tailed Wilcoxon 
matched pairs test.
Our findings indicate that Rd LOS to be able to induce significantly higher levels of IgG in our 
healthy individual sample population (Fig. 17) (PcO.Ol). As these results are paired observations, 
differences due to serum variability are minimized. Therefore, we can safely conclude this 
observed difference in our sample population accurately reflects the true antibody concentrations 
of the members included in our population.
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5. Discussion
Adaptive immunity is a critical component in microbial clearance following infection. As such, 
with regards to Haemophilus influenzae, its effect in the stimulation and/or evasion of the 
adaptive immune response has been of great interest. However, the role of the conserved 
glycoplipid LOS of H. influenzae in the adaptive immune paradigm is an area which has not 
been fully elucidated. It has been shown that LOS can act as both a direct and indirect virulence 
factor; the presence of LOS directly enhances evasion of host mechanism while acting as a 
scaffold which can bind to several different virulence factors which also enhance bacterial 
evasion (Swords, Jones et al. 2003, Hallstrom and Riesbeck 2010, Clark, Snow et al. 2012). 
Interestingly, a recent study had shown the LOS structure allowed for decreased binding by IgM 
thereby decreasing IgM-mediated complement killing (Langereis, Stol et al. 2012). These studies 
have highlighted the overall effect of LOS in the adaptive immune response; however a more 
fundamental question has not been fully addressed in the literature. It is clear that the LOS 
structure has several roles in enhancing the overall virulence of H. influenzae; however, it is 
unclear whether this structure is antigenic enough to elicit a natural LOS specific antibody 
response and whether this can be observed in human populations.
In this study we have shown that both Eagan and Rd LOS structures are sufficiently antigenic to 
induce a natural LOS specific antibody response. The therapeutic implications of this finding 
would mean novel targets for vaccine development, however further investigation into whether 
these apparent LOS specific antibodies are capable of bactericidal activity would be required. 
We also found, in the case of Eagan LOS, the antibody response suggested age dependence
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whereas this effect was not observed, in the case of antibodies against Rd LOS. Extrapolation 
from a closed ex vivo sample population to the entire population should always be made 
conservatively. Having said that, a possible explanation for the higher anti-Eagan LOS IgG 
levels observed in the mid age group could be due to the correlation between the expansion of 
B-memory cell repertoire and increasing age (Aberle and Puchhammer-Stockl 2012). Older 
individuals have been exposed to more antigenic compounds than younger individuals leading to 
a constitution of a broader more robust immune memory repertoire. However, with elderly 
individuals, generally 60 years and older, this repertoire typically succumbs to degradation; this 
decrease in IgG was also observed with the old age group although the difference was not 
statistically significant (Fig. 15).
It is important to address the intentional exclusion of Rd licllpsA  from the assays performed in 
this chapter. As these mutations were created in a laboratory setting, i.e. for the purpose of 
testing compositional effect of the wildtype, it did not exist in the natural world. Consequently, 
using this compound as an antigen of interest for serum samples was considered irrelevant.
Our results also suggest a disparity in the immunogenicity between Eagan and Rd LOS 
compounds. Within our population of 72 samples, there were significantly higher IgG levels 
found against Rd than Eagan LOS (Fig. 17). According to our statistical analysis, we can infer, 
for the rest of our geographical region, a higher IgG level against Rd LOS to be present than 
Eagan LOS. This may be due to multiple factors; the Rd LOS structure may simply be more 
antigenic than the Eagan LOS, however this explanation is not completely satisfactory. The 
Eagan strain belongs to the serotype b, which was historically the most virulent serotype of H. 
influenzae. Thus it is difficult to reproach this disparity on the basis of antigenicity. Another
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possible explanation could be epidemiological; this region may have been in more frequent 
contact with the Rd serotype and consequently developed more antibodies against that specific 
LOS. Moreover, with the introduction of the Hib conjugate vaccine, invasive infection caused by 
Hib has been virtually eliminated in developed countries (Kelly, Moxon et al. 2004). As the Hib 
vaccine is not selective for the Rd serotype d strain, this type of ecological environment could 
promote colonization by the Rd strain. This explains why the younger age group showed 
significantly less anti-Eagan LOS IgG, since they would have grown up in a post-Hib vaccine era, 
and thereby was subjected to a herd effect of immunization. In contrast, in the absence of this 
herd effect, the mid and older age groups would have been in frequent contact with Hib resulting 
in immunological memory against its antigens. This explanation does seem plausible however , 
further investigation into various epidemiological factors would be warranted.
If we attempt to create a comprehensive picture of the effect of LOS on both innate and adaptive 
immunity, we must first understand the scope of these two chapters and their limitations. There 
exists a disconnect between the results of the immunostimulatory nature of LOS shown in 
chapter I and the antibody production capacity of LOS shown in chapter II. As LOS is a non­
protein antigen, this implies that the co-stimulatory and antigen presenting molecules measured 
in chapter I would not have a direct effect on the production of antibodies against LOS. In other 
words there is no direct relationship between the upregulation of co-stimulatory and antigen 
presenting molecules and the production of antibodies for non-protein antigens. Consequently, 
conclusions cannot be made in the same way as if LOS had been a peptide antigen; however this 
does not mean the exhibited immunostimulatory nature of LOS does not play a role in antibody 
production. It has been shown that TLR4 activation is crucial for the in vivo generation of long-
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lived antibody secreting cells (Komegae, Grund et al. 2013), which suggests that there is
undoubtedly an essential role for LOS in the production of antibodies.
In summary, we have shown both Eagan and Rd LOS compounds are capable in eliciting LOS 
specific IgG in healthy individuals. In addition, higher IgG levels were found against Rd LOS 
when compared with Eagan LOS. This is possibly due to epidemiological factors influencing our 
sample population, specifically the H. influenzae Rd strain may be more geographically 
prevalent than the Eagan strain. However these findings do support the possible benefits of
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Median: 0.4519 0.6752 0.4368 :
n= 24 28 20
Figure 15. The presence of naturally acquired IgG against Eagan LOS in healthy 
individuals. Serum samples were run in an indirect ELISA, using microplates coated with Eagan 
LOS. One serum sample was chosen arbitrarily to be the relative standard to compare all other 
samples. All samples were normalized to the standard and the results were expressed in relative 
units. Age groups were determined by established SENIEUR protocol with modifications. Data 














G M C: 1.42 1.68 1.62
C l 95% : 1.01 - 1.98 1.11-2.54 1.03-2.54
M edian: 1.86 1.35 1.53
n= 24 28 20
Figure 16. The presence of naturally acquired IgG against Rd LOS in healthy individuals.
Serum samples were run in an indirect ELISA, using microplates coated with Rd LOS. One 
serum sample was chosen arbitrarily to be the relative standard to compare all other samples. All 
samples were normalized to the standard and the results were expressed in relative units. Age 
groups were determined by established SENIEUR protocol with modifications. Data shows 
GMC ± Cl 95% where *P<0.05. (GMC) geometric mean; (Cl) confidence intervals.
56







Eagan IgG Rd IgG
GM C: 1.107 1.636
C l 95% : 0.9335- 1.312 1.312-2.040
M edian: 1.076 1.537
n= 72 72
Figure 17. A comparative analysis of total IgG levels in sample population. Serum samples 
were run in an indirect ELISA, using microplates coated with LOS of interest and results were 
expressed in raw O.D. values. Data shows GMC ± Cl 95%. Statistical significance was 
determined by a two tailed Wilcoxon matched pairs test where *P<0.05. (GMC) geometric 
mean; (Cl) confidence intervals.
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Conclusion
The aim of these studies was to address the fundamental properties of the conserved endotoxin, 
LOS, of Haemophilus influenzae. Although LOS had been the focus of many studies, we felt that 
there were two questions that were not fully addressed in the literature. First, it had not been 
adequately shown whether LOS of H. influenzae could activate the innate and inflammatory 
responses. Second, it was also uncertain whether a natural immune response to LOS can result in 
an antigen-specific antibody response; furthermore, this had not been shown using a human 
sample population.
Our findings show that the LOS compounds derived from Eagan and Rd serotypes were able to 
induce an inflammatory response, however, this response was significantly lower when 
compared with the toxic LPS compound from E. coli. It was also shown that Rd lie lips A LOS 
induced consistently higher expression of inflammatory cytokines and adhesion molecules than 
the wildtype, suggesting a role for phosphorylcholine and oligosaccharide additions in 
suppressing the immune system.
We found that healthy individuals are capable of producing LOS specific antibodies against 
Eagan and Rd strains. The IgG isotype was measured because its presence would indicate a 
secondary response since people are generally asymptomatically colonized by H. influenzae and 
therefore a primary immune encounter should have already occurred. Interestingly, we observed 
significantly higher IgG levels against Rd LOS than Eagan LOS in the same serum samples. We 
suggest that there may be epidemiological factors that may explain the observed results.
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These findings help provide some of the missing pieces of our collective understanding of host- 
pathogen interactions with Haemophilus influenzae. The role of LOS with regards to inducing 
the innate immune response and how this effect had translated into antibody production gives us 
insight into the larger scope of the human immune response in its entirety. Granted, there are still 
many questions with regards to the specific mechanisms behind the observed responses, however 
the overall immunological effect of LOS was shown.
The clinical applications of these findings highlight both Eagan and Rd LOS structures as 
potential candidates for vaccine and/or adjuvant development. As disease caused by non-type b 
H. influenzae strains are of growing concern, a LOS structure that has a low immunostimulatory 
potential but that is antigenic enough to elicit antibody production warrant serious consideration 
as a possible prophylactic treatment option.
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